BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 15880642)

  • 21. Direct AKAP-mediated protein-protein interactions as potential drug targets.
    Hundsrucker C; Klussmann E
    Handb Exp Pharmacol; 2008; (186):483-503. PubMed ID: 18491065
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Strategies to search and design stabilizers of protein-protein interactions: a feasibility study.
    Block P; Weskamp N; Wolf A; Klebe G
    Proteins; 2007 Jul; 68(1):170-86. PubMed ID: 17393392
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ligand-regulated peptides: a general approach for modulating protein-peptide interactions with small molecules.
    Binkowski BF; Miller RA; Belshaw PJ
    Chem Biol; 2005 Jul; 12(7):847-55. PubMed ID: 16039531
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Peptides as protein binding site mimetics.
    Eichler J
    Curr Opin Chem Biol; 2008 Dec; 12(6):707-13. PubMed ID: 18935974
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Small-molecule inhibitors of protein-protein interactions: progressing towards the dream.
    Arkin MR; Wells JA
    Nat Rev Drug Discov; 2004 Apr; 3(4):301-17. PubMed ID: 15060526
    [No Abstract]   [Full Text] [Related]  

  • 26. Protein-protein interactions and cancer: small molecules going in for the kill.
    Arkin M
    Curr Opin Chem Biol; 2005 Jun; 9(3):317-24. PubMed ID: 15939335
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthetic non-peptide mimetics of alpha-helices.
    Davis JM; Tsou LK; Hamilton AD
    Chem Soc Rev; 2007 Feb; 36(2):326-34. PubMed ID: 17264933
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Screening for transient biological interactions as applied to albumin ligands: a new concept for drug discovery.
    Ohlson S; Shoravi S; Fex T; Isaksson R
    Anal Biochem; 2006 Dec; 359(1):120-3. PubMed ID: 17052679
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predicting the multi-modal binding propensity of small molecules: towards an understanding of drug promiscuity.
    Park K; Lee S; Ahn HS; Kim D
    Mol Biosyst; 2009 Aug; 5(8):844-53. PubMed ID: 19603120
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NMR studies of protein interactions.
    Takeuchi K; Wagner G
    Curr Opin Struct Biol; 2006 Feb; 16(1):109-17. PubMed ID: 16427776
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Halogen bonding--a novel interaction for rational drug design?
    Lu Y; Shi T; Wang Y; Yang H; Yan X; Luo X; Jiang H; Zhu W
    J Med Chem; 2009 May; 52(9):2854-62. PubMed ID: 19358610
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The use of protein-ligand interaction fingerprints in docking.
    Brewerton SC
    Curr Opin Drug Discov Devel; 2008 May; 11(3):356-64. PubMed ID: 18428089
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibiting HIV-1 integrase by shifting its oligomerization equilibrium.
    Hayouka Z; Rosenbluh J; Levin A; Loya S; Lebendiker M; Veprintsev D; Kotler M; Hizi A; Loyter A; Friedler A
    Proc Natl Acad Sci U S A; 2007 May; 104(20):8316-21. PubMed ID: 17488811
    [TBL] [Abstract][Full Text] [Related]  

  • 34. General and targeted statistical potentials for protein-ligand interactions.
    Mooij WT; Verdonk ML
    Proteins; 2005 Nov; 61(2):272-87. PubMed ID: 16106379
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular modeling of hydration in drug design.
    Mancera RL
    Curr Opin Drug Discov Devel; 2007 May; 10(3):275-80. PubMed ID: 17554853
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Between a rock and a hard place?
    Whitty A; Kumaravel G
    Nat Chem Biol; 2006 Mar; 2(3):112-8. PubMed ID: 16484997
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mapping the integrin-linked kinase interactome using SILAC.
    Dobreva I; Fielding A; Foster LJ; Dedhar S
    J Proteome Res; 2008 Apr; 7(4):1740-9. PubMed ID: 18327965
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protein-protein interactions as new drug targets. Preface.
    Klussmann E; Rosenthal W
    Handb Exp Pharmacol; 2008; (186):v-vi. PubMed ID: 18634198
    [No Abstract]   [Full Text] [Related]  

  • 39. Structural genomics and drug discovery: all in the family.
    Weigelt J; McBroom-Cerajewski LD; Schapira M; Zhao Y; Arrowsmith CH
    Curr Opin Chem Biol; 2008 Feb; 12(1):32-9. PubMed ID: 18282486
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combination of a modified scoring function with two-dimensional descriptors for calculation of binding affinities of bulky, flexible ligands to proteins.
    Hetényi C; Paragi G; Maran U; Timár Z; Karelson M; Penke B
    J Am Chem Soc; 2006 Feb; 128(4):1233-9. PubMed ID: 16433540
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.